187 related articles for article (PubMed ID: 30643112)
21. Severe hypersensitivity reactions to platinum compounds post-pressurized intraperitoneal aerosol chemotherapy (PIPAC): first literature report.
Siebert M; Alyami M; Mercier F; Gallice C; Villeneuve L; Bérard F; Glehen O; Bakrin N; Kepenekian V
Cancer Chemother Pharmacol; 2019 Mar; 83(3):425-430. PubMed ID: 30511218
[TBL] [Abstract][Full Text] [Related]
22. Next-generation sequencing and histological response assessment in peritoneal metastasis from pancreatic cancer treated with PIPAC.
Nielsen M; Graversen M; Ellebæk SB; Kristensen TK; Fristrup C; Pfeiffer P; Mortensen MB; Detlefsen S
J Clin Pathol; 2021 Jan; 74(1):19-24. PubMed ID: 32385139
[TBL] [Abstract][Full Text] [Related]
23. Pressurized Intraperitoneal Aerosol Chemotherapy, a Palliative Treatment Approach for Patients With Peritoneal Carcinomatosis: Description of Method and Systematic Review of Literature.
Winkler CS; Sandhu J; Pettke E; Merchea A; Fong Y; Kumara HMCS; Whelan RL
Dis Colon Rectum; 2020 Feb; 63(2):242-255. PubMed ID: 31914116
[TBL] [Abstract][Full Text] [Related]
24. Pressurized Intraperitoneal Aerosol Chemotherapy with Cisplatin and Doxorubicin in Women with Peritoneal Carcinomatosis: A Cohort Study.
Tempfer CB; Rezniczek GA; Ende P; Solass W; Reymond MA
Anticancer Res; 2015 Dec; 35(12):6723-9. PubMed ID: 26637888
[TBL] [Abstract][Full Text] [Related]
25. Treatment of Peritoneal Metastasis with Pressurized Intraperitoneal Aerosol Chemotherapy: Results from the Prospective PIPAC-OPC2 Study.
Graversen M; Detlefsen S; Ainsworth AP; Fristrup CW; Knudsen AO; Pfeiffer P; Tarpgaard LS; Mortensen MB
Ann Surg Oncol; 2023 May; 30(5):2634-2644. PubMed ID: 36602663
[TBL] [Abstract][Full Text] [Related]
26. Pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin or oxaliplatin for peritoneal metastasis from pancreatic adenocarcinoma and cholangiocarcinoma.
Di Giorgio A; Sgarbura O; Rotolo S; Schena CA; Bagalà C; Inzani F; Russo A; Chiantera V; Pacelli F
Ther Adv Med Oncol; 2020; 12():1758835920940887. PubMed ID: 32782488
[TBL] [Abstract][Full Text] [Related]
27. PIPAC-OX: A Phase I Study of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy in Patients with Peritoneal Metastases.
Kim G; Tan HL; Sundar R; Lieske B; Chee CE; Ho J; Shabbir A; Babak MV; Ang WH; Goh BC; Yong WP; Wang L; So JBY
Clin Cancer Res; 2021 Apr; 27(7):1875-1881. PubMed ID: 33148667
[TBL] [Abstract][Full Text] [Related]
28. First Clinical Safety and Feasibility Data of Whole-body Hyperthermia Pressurized Intraperitoneal Aerosol Chemotherapy (WBH-PIPAC) for Peritoneal Surface Malignancies.
Kockelmann F; Giger-Pabst U; Ouaissi M; Bucur P; Barbey S; VON Ardenne A; Zieren J
Anticancer Res; 2024 Jul; 44(7):3043-3050. PubMed ID: 38925817
[TBL] [Abstract][Full Text] [Related]
29. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for rare gynecologic indications: peritoneal metastases from breast and endometrial cancer.
Rezniczek GA; Giger-Pabst U; Thaher O; Tempfer CB
BMC Cancer; 2020 Nov; 20(1):1122. PubMed ID: 33213407
[TBL] [Abstract][Full Text] [Related]
30. Feasibility, Safety, and Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastasis: A Registry Study.
Kurtz F; Struller F; Horvath P; Solass W; Bösmüller H; Königsrainer A; Reymond MA
Gastroenterol Res Pract; 2018; 2018():2743985. PubMed ID: 30473706
[TBL] [Abstract][Full Text] [Related]
31. Pressurized Intra Peritoneal Aerosol Chemotherapy in patients suffering from peritoneal carcinomatosis of pancreatic adenocarcinoma.
Khosrawipour T; Khosrawipour V; Giger-Pabst U
PLoS One; 2017; 12(10):e0186709. PubMed ID: 29049340
[TBL] [Abstract][Full Text] [Related]
32. Pressurized Intraperitoneal Aerosol Chemotherapy for Colorectal Peritoneal Metastases.
Tabchouri N; Buggisch J; Demtröder CR; Thiery J; Rezniczek G; Tempfer CB; Fischer B; Dogan C; Lecomte T; Ouaissi M; Giger-Pabst U
Ann Surg Oncol; 2021 Sep; 28(9):5275-5286. PubMed ID: 33471267
[TBL] [Abstract][Full Text] [Related]
33. A phase I, single-arm, open-label, dose escalation study of intraperitoneal cisplatin and doxorubicin in patients with recurrent ovarian cancer and peritoneal carcinomatosis.
Tempfer CB; Giger-Pabst U; Seebacher V; Petersen M; Dogan A; Rezniczek GA
Gynecol Oncol; 2018 Jul; 150(1):23-30. PubMed ID: 29743140
[TBL] [Abstract][Full Text] [Related]
34. Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, phase II study (CRC-PIPAC).
Rovers KP; Lurvink RJ; Wassenaar EC; Kootstra TJ; Scholten HJ; Tajzai R; Deenen MJ; Nederend J; Lahaye MJ; Huysentruyt CJ; van 't Erve I; Fijneman RJ; Constantinides A; Kranenburg O; Los M; Thijs AM; Creemers GM; Burger JW; Wiezer MJ; Boerma D; Nienhuijs SW; de Hingh IH
BMJ Open; 2019 Jul; 9(7):e030408. PubMed ID: 31352425
[TBL] [Abstract][Full Text] [Related]
35. Renal and hepatic toxicities after pressurized intraperitoneal aerosol chemotherapy (PIPAC).
Blanco A; Giger-Pabst U; Solass W; Zieren J; Reymond MA
Ann Surg Oncol; 2013 Jul; 20(7):2311-6. PubMed ID: 23377563
[TBL] [Abstract][Full Text] [Related]
36. Bidirectional Approach with PIPAC and Systemic Chemotherapy for Patients with Synchronous Gastric Cancer Peritoneal Metastases (GCPM).
Casella F; Bencivenga M; Brancato G; Torroni L; Ridolfi C; Puccio C; Alloggio M; Meloni F; Fusario D; Marrelli D; Giacopuzzi S; Roviello F; de Manzoni G
Ann Surg Oncol; 2023 Sep; 30(9):5733-5742. PubMed ID: 37270440
[TBL] [Abstract][Full Text] [Related]
37. Clinical Outcome for Patients Managed with Low-Dose Cisplatin and Doxorubicin Delivered as Pressurized Intraperitoneal Aerosol Chemotherapy for Unresectable Peritoneal Metastases of Gastric Cancer.
Sindayigaya R; Dogan C; Demtröder CR; Fischer B; Karam E; Buggisch JR; Tempfer CB; Lecomte T; Ouaissi M; Giger-Pabst U
Ann Surg Oncol; 2022 Jan; 29(1):112-123. PubMed ID: 34611790
[TBL] [Abstract][Full Text] [Related]
38. Treatment of peritoneal carcinomatosis with Pressurized IntraPeritoneal Aerosol Chemotherapy - PIPAC-OPC2.
Graversen M; Detlefsen S; Asmussen J; Mahdi B; Fristrup C; Pfeiffer P; Mortensen MB
Pleura Peritoneum; 2018 Jun; 3(2):20180108. PubMed ID: 30911656
[TBL] [Abstract][Full Text] [Related]
39. PIPAC-OV3: A multicenter, open-label, randomized, two-arm phase III trial of the effect on progression-free survival of cisplatin and doxorubicin as Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) vs. chemotherapy alone in patients with platinum-resistant recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer.
Bakrin N; Tempfer C; Scambia G; De Simone M; Gabriel B; Grischke EM; Rau B
Pleura Peritoneum; 2018 Sep; 3(3):20180114. PubMed ID: 30911662
[TBL] [Abstract][Full Text] [Related]
40. Prospective, single-center implementation and response evaluation of pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastasis.
Graversen M; Detlefsen S; Bjerregaard JK; Fristrup CW; Pfeiffer P; Mortensen MB
Ther Adv Med Oncol; 2018; 10():1758835918777036. PubMed ID: 29899763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
